Are Analysts Expecting A Better 2020 For Allogene Therapeutics Inc (ALLO)?

Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $1.66, with 7.01 million shares of worth about $11.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.78% during that period and on July 23, 2025 the price saw a […]

Technical Outlook And Game Plan For Allogene Therapeutics Inc (NASDAQ: ALLO)

Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $1.21, with 9.59 million shares of worth about $11.6 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -43.98% during that period and on July 09, 2025 the price saw a […]

Is There More Upside Ahead For Allogene Therapeutics Inc (NASDAQ: ALLO)

Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $1.2, with 4.81 million shares of worth about $5.77 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.21% during that period and on July 02, 2025 the price saw a […]

Is There More Upside Ahead For Allogene Therapeutics Inc (NASDAQ: ALLO)

Allogene Therapeutics Inc (ALLO) concluded trading on Wednesday at a closing price of $4.15, with 4.08 million shares of worth about $16.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.95% during that period and on Wednesday February 7 the price saw a […]

Analyst Expect Big Moves From Allogene Therapeutics Inc (NASDAQ: ALLO)

Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]

Allogene Therapeutics Inc (NASDAQ: ALLO): Hunting Genuine Value In Market Debris

Fidelity Management & Research Co recently announced the acquisition of new stake in Allogene Therapeutics Inc (NASDAQ:ALLO). The institutional investor has increased its shareholding in the Healthcare company by 0.91% to 25.14 million shares with purchase of 0.23 million shares. This fresh investment now brings its stake to 14.94% valued currently at $59.09 million. In […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.